http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103919779-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-12 |
filingDate | 2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103919779-B |
titleOfInvention | A kind of pharmaceutical composition containing Moxifloxacin |
abstract | The present invention relates to a kind of pharmaceutical composition containing Moxifloxacin, it is characterized in that said composition is made up of Moxifloxacin or its salt and sodium lactate ringer's injection, specifically consist of: in every this pharmaceutical composition of 100ml containing Moxifloxacin or its salt 0.1 ~ 0.4 gram by Moxifloxacin, 0.54 ~ 0.66 gram, sodium chloride, sodium lactate 0.28 ~ 0.34 gram, 0.027 ~ 0.033 gram, potassium chloride, calcium chloride CaCln 2 .2Hn 2 00.018 ~ 0.022 gram.Pharmaceutical composition of the present invention, Moxifloxacin or its salt dissolubility good, pharmaceutical composition stable in properties. |
priorityDate | 2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.